All articles by Jamie Durrani – Page 16
-
BusinessMerck & Co and Qiagen to build UK research hubs
Almost 2000 jobs to be created at research centres in Manchester and London
-
ResearchAncient Egyptian uprisings triggered by volcanic eruptions
New evidence that changes in atmospheric chemistry caused social stresses and uprisings against the ruling elite
-
BusinessLilly and CureVac to collaborate on mRNA cancer vaccines
Deal could see CureVac net up to $1.8 billion in upfront and milestone payments
-
ReviewA crack in creation: the new power to control evolution
How studying bacterial immunity led to the development of Crispr
-
ResearchReductive power of hydrated electrons unleashed with green lasers
New technique produces solvated electrons with a visible-light responsive photocatalyst
-
![X ray single crystal structure of Cucurbit[7]uril binding an amphetamine](https://d2cbg94ubxgsnp.cloudfront.net/Pictures/100x67/3/4/8/133348_X-ray-single-crystal-structure-of-2-CB-7-.jpg)
ResearchSynthetic receptor spots amphetamines speedily
Portable drug-detection device can send results directly to a smartphone
-
ResearchSuper-electrophilic ions enable selective modification of bioactive molecules
New technique will help medicinal chemists explore chemical space
-
BusinessAlexion axes 20% of its global workforce
600 jobs lost amid restructure as firm moves to Boston life sciences hub
-
BusinessTeva sells off contraceptive device in $1.1bn deal
CooperSurgical to acquire Paragard as Teva seeks to offload assets
-
BusinessFDA warns Pfizer subsidiary over Epipen malfunctions
Manufacturer did not fully investigate reports of patients dying after auto-injector failures
-
BusinessEU investigates Bayer’s Monsanto takeover plan
Commission raises concerns over reduced competition across pesticide and seed markets
-
BusinessMexichem to buy Netafim in $1.5bn deal
Takeover brings Netafim’s smart irrigation technology that could be applied across other markets
-
ResearchCatalyst made from plant roots promotes Suzuki reaction
Ecocatalyst recycling strategy could be used to recover precious metal pollutants from contaminated sites
-
BusinessBroad Institute backs central Crispr patent licensing platform
Key players submit 22 patents to pool, and urge other holders to create a one-stop shop for licensing deals
-
BusinessSilence Therapeutics and Alnylam in patent dispute
Suit alleges competitors need to license Silence patents relating to their drug cantidates
-
NewsHeavy metal's revenge
Climate change could see levels of toxic mercury rise again even as the world cuts emissions
-
ResearchPolymer 'worm' is walking on sunshine
Light-responsive plastic film can match a caterpillar for speed and can even transport objects
-
ResearchOcean chemistry was responsible for 2015 Monterey Bay disaster
Unusual balance of nutrients allowed algae to build up high concentrations of neurotoxin
-
ResearchLight-driven catalytic process offers greener route to organic alcohols
Cobalt–copper system works in water and tolerates air
-
BusinessEuropean Commission to investigate excessive drug pricing
Inquiry covers claims that Aspen Pharma’s price rises on five cancer treatments were unjustified